/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Every assumption below is yours to change. The defaults are derived from this company's own filing history, not from a house view.
Conservative
$53.86
68% overvaluedvs $168.66
Base
$91.59
46% overvaluedvs $168.66
Optimistic
$174.01
3% undervaluedvs $168.66
Today's price falls inside the modelled range.
Verdict
Today's price sits inside the range but 46% above the base case. Upside from here requires beating your own base assumptions.
Base free cash flow
$74M
Trailing twelve months
Historical FCF CAGR
+39.4%
Across 6 reported periods
Market implies
25.6%
Growth needed at 8% WACC
Terminal value share
69%
Of the base case valuation
At a 8.0% discount rate, today's price already assumes 25.6% annual free cash flow growth for ten years. Your base case assumes 20.0%, so the market is paying for growth you are not forecasting.
Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.
The most recent period is the base every projection starts from. Compounded, that history is +39.4% a year.
Intrinsiqq's two-stage DCF values PriceSmart (PSMT) at about $122.12 per share, or $91.59 with a 25% margin of safety. At $168.66 the stock looks overvalued. Every assumption is adjustable below; this is analysis, not investment advice.
SourceFair value computed from the 10-Q filed 8 Jul 2026, covering the period ending 31 May 2026, as reported to the SEC. Data last refreshed 9 Jul 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Aug.
Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about $122.12 per share for PSMT. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $91.59. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.
At $168.66, PSMT trades above the base-case intrinsic value of about $122.12, a 27.6% premium over that estimate, so on this model it looks overvalued. A DCF is only one lens: a premium can be justified if the business grows faster or is higher quality than the base case assumes, which is exactly what the sliders let you test.
The base case grows PSMT's free cash flow at about 20.0% a year before fading, against roughly 39.4% historical free-cash-flow growth. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.
A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns PSMT's $122.12 intrinsic estimate into a $91.59 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from SEC filings, not investment advice.